FIELD: medicine.
SUBSTANCE: proposed are compositions for treatment of a pulmonary disease or disorder, deliverable from an inhaler with measured dosage. In one implementation, the compositions comprise a suspension medium, active substance particles and suspending particles, wherein the active substance particles and the suspending particles form a co-suspension in the suspension medium.
EFFECT: creation of compositions for treatment of a pulmonary disease or disorder for use in an inhaler.
35 cl, 39 dwg, 27 tbl, 26 ex
Authors
Dates
2021-07-16—Published
2010-05-28—Filed